2017 annual financial data
XTL Biopharmaceuticals 2017 Operating margin
Direct answer
Operating margin was -4,296.55%.
Operating income was -1,246,000 USD and net income was -781,000 USD.
Operating cash flow was -1,125,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 29,000 USD
- Operating income
- -1,246,000 USD
- Net income
- -781,000 USD
- Operating cash flow
- -1,125,000 USD